Prolonged electromechanical delay as an early predictor of trastuzumab-induced cardiotoxicity in patients undergoing treatment for breast cancer.
Jeong Cheon ChoeJung Hyun ChoiJong Hyun ChoiJinhee AhnJin Sup ParkHye Won LeeJun-Hyok OhHan Cheol LeeKwang Soo ChaTaek Jong HongPublished in: Clinical cardiology (2018)
ΔLVEMDi and ΔLVEMDp may serve as predictors of subclinical cardiac dysfunction in breast cancer patients receiving trastuzumab.